Skip to content

Study · Case report or series · n = 1 · 2014

2 results

Melanoma associated with the use of melanotan-II.

Hjuler KF, Lorentzen HF

Dermatology (Basel, Switzerland)18 Dec 2013Cited by 20 (Europe PMC)

PMID24355990 (opens in a new tab)DOI10.1159/000356389 (opens in a new tab)PepBankPUB-24355990
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesSafety outcome

    A woman who self-injected melanotan II for 3 to 4 weeks, three months before excision, and also used sunbed tanning was diagnosed with cutaneous melanoma.

    In plain wordsA young woman who injected melanotan II and used sunbeds was found to have melanoma. The report does not prove melanotan II caused it.

    Peptide
    Melanotan II
    Outcome
    Not applicableCutaneous melanoma after melanotan II use
    Study

    n = 1

    Outcome group
    Adverse events · Skin and wound
    Studied dose
    Dose not stated · subcutaneous injection · 3-4 weeksAs given in this study (human).

    Source sentences

    Summary
    The melanocytic lesion was excised, and histology confirmed the diagnosis of melanoma.
    2 context sentences
    Summary · context
    Three months prior to the excision the patient had conducted a 3- to 4-week course of self-injections with MT-II, intending an augmentation of sunbed tanning.
    Summary · context
    A 20-year-old woman with Fitzpatrick skin type II was referred to a dermatology clinic.
  2. 02HumanCase report or seriesEfficacy outcome

    A woman who used melanotan II had universally intensely pigmented skin at examination.

    In plain wordsA woman who used melanotan II had very dark skin all over when examined.

    Peptide
    Melanotan II
    Outcome
    IncreaseSkin pigmentation
    Study

    n = 1

    Outcome group
    Pigmentation · Skin and wound
    Studied dose
    Dose not stated · subcutaneous injection · 3-4 weeksAs given in this study (human).

    Source sentences

    Summary
    Furthermore, her skin was universally intensely pigmented.
    2 context sentences
    Summary · context
    Three months prior to the excision the patient had conducted a 3- to 4-week course of self-injections with MT-II, intending an augmentation of sunbed tanning.
    Summary · context
    A 20-year-old woman with Fitzpatrick skin type II was referred to a dermatology clinic.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.